tiprankstipranks
Marinomed Biotech AG (DE:93Z)
FRANKFURT:93Z
Germany Market
93Z
Marinomed Biotech AG
RESEARCH TOOLSreports
Want to see DE:93Z full AI Analyst Report?

Marinomed Biotech AG (93Z) Income Statement

0 Followers

Marinomed Biotech AG Income Statement

Last quarter (Q2 2024), Marinomed Biotech AG's total revenue was €1.73M, a decrease of -9.59% from the same quarter last year. In Q2, Marinomed Biotech AG's net income was €-8.70M. See Marinomed Biotech AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Dec 21Dec 20Dec 19
Total Revenue
€ 9.18M€ 11.28M€ 11.63M€ 8.12M€ 6.14M
Gross Profit
€ 1.14M€ 2.14M€ 1.42M€ -641.70K€ -512.30K
Operating Expenses
€ 6.27M€ 7.05M€ 5.57M€ 5.17M€ 5.78M
Depreciation and Amortization
€ 678.20K€ 669.70K€ 608.90K€ 428.40K€ 327.20K
EBITDA
€ -3.62M€ -3.21M€ -3.58M€ -4.86M€ -6.22M
Operating Income
€ -5.13M€ -5.75M€ -4.14M€ -6.96M€ -6.21M
Other Income/Expenses
€ -1.66M€ -639.60K€ -1.55M€ 954.10K€ -1.00M
Pretax Income
€ -6.79M€ -6.39M€ -5.69M€ -6.01M€ -7.21M
Net Income
€ -6.79M€ -6.40M€ -5.89M€ -6.01M€ -7.22M
Per Share Metrics
Basic EPS
€ -4.48€ -4.27€ -3.99€ -4.09€ -5.09
Diluted EPS
€ -4.50€ -4.27€ -3.99€ -4.09€ -5.09
Weighted Average Shares Outstanding
 1.52M 1.50M 1.48M 1.47M 1.42M
Weighted Average Shares Outstanding (Diluted)
 1.52M 1.50M 1.48M 1.47M 1.42M
Currency in EUR

Marinomed Biotech AG Earnings and Revenue History